SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001654954-19-002000
Filing Date
2019-02-26
Accepted
2019-02-26 17:00:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A sc13da_feb142019.htm SC 13D/A 107644
  Complete submission text file 0001654954-19-002000.txt   109006
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Subject) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D/A | Act: 34 | File No.: 005-89966 | Film No.: 19634284
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O JDJ FAMILY OFFICE SERVICES P.O. BOX 962049 BOSTON MA 02196
Business Address
Ross Edmund Burke Jr. (Filed by) CIK: 0001682557 (see all company filings)

Type: SC 13D/A